Effectiveness and safety of convalescent anti SARS-CoV-2 plasma in the treatment of the early phase of novel coronavirus infection (COVID-19) in hospitalized risk patients: an interventional randomized clinical study

Balcells, MarÍa Elvira; Ceballos, María Elena

Más información

Fecha de publicación: 2020
Objetivos: Currently there is no standard treatment for SARS-CoV-2 infection. Use of convalescent plasma has been studied in outbreaks of other respiratory infections, including SARS-CoV-1 , MERS-CoV and Hantavirus infection. This study is an openlabel randomized trial in which patients with high risk of COVID
Año de Inicio/Término: 2020-2020
Financiamiento/Sponsor: Fondo de Adopción Tecnológica SiEmpre SOFOFA Hub
Rol del Usuario: COINVESTIGADOR(A)
URL: https://clinicaltrials.gov/ct2/show/NCT04375098
DOI:

200415015